← Back to Search

Sharp Needles for Needlestick Injuries

N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group

Summary

The objective of this study was to determine if blunt needle use during cesarean section closure protects against glove perforation and percutaneous injury to the surgeon and surgical assistant. A secondary objective was to determine physician satisfaction with blunt needles during the surgery.

Eligible Conditions
  • Needlestick Injuries
  • Needlestick Injury
  • Glove Perforations

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of observed glove perforations
Secondary study objectives
Physician satisfaction with the needle assignment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Sharp NeedlesActive Control1 Intervention
Sharp needles to close uterus, fascia and skin during cesarean section
Group II: Blunt NeedlesActive Control1 Intervention
Assignment to blunt needles to close uterus, fascia and skin during cesarean section

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
972 Previous Clinical Trials
7,399,108 Total Patients Enrolled
1 Trials studying Needlestick Injuries
438 Patients Enrolled for Needlestick Injuries
Scott A Sullivan, MDStudy DirectorMedical University of South Carolina
1 Previous Clinical Trials
350 Total Patients Enrolled
~9 spots leftby Nov 2025